HomeOCUP • NASDAQ
Follow
Ocuphire Pharma Inc
Previous close
$2.02
Day range
$1.99 - $2.03
Year range
$1.85 - $6.60
Market cap
49.87M USD
Avg Volume
203.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.69M | -95.76% |
Operating expense | 19.86M | 26.78% |
Net income | -4.80M | -114.13% |
Net profit margin | -283.56 | -432.93% |
Earnings per share | -0.21 | -112.43% |
EBITDA | -5.43M | -115.86% |
Effective tax rate | 0.04% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 50.52M | 18.35% |
Total assets | 53.95M | 10.12% |
Total liabilities | 4.04M | 46.82% |
Total equity | 49.91M | — |
Shares outstanding | 24.81M | — |
Price to book | 0.97 | — |
Return on assets | -25.10% | — |
Return on capital | -27.09% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.80M | -114.13% |
Cash from operations | 4.55M | -84.20% |
Cash from investing | — | — |
Cash from financing | 3.60M | 30,125.00% |
Net change in cash | 8.15M | -71.68% |
Free cash flow | 5.02M | -68.96% |
About
Founded
2018
Headquarters
Website
Employees
14